eMedicine Specialties > Physical Medicine and Rehabilitation > Medical Diseases

Cerebral Palsy

Author: Christine Thorogood, MD, Associate Professor of Pediatric Physical Medicine and Rehabilitation, Eastern Virginia Medical School
Coauthor(s): Michael A Alexander, MD, FAAPMR, FAAP, Professor, Chief of Division of Rehabilitation Medicine, Departments of Pediatrics and Rehabilitation Medicine, Thomas Jefferson Medical College; Chief of Rehabilitation Medicine, Alfred I duPont Hospital for Children
Contributor Information and Disclosures

Updated: Mar 11, 2009

Introduction

Background

Cerebral palsy is a disorder affecting the development of movement and posture that is believed to arise from nonprogressive disturbances in the developing fetal or infant brain. In addition to the motor disorders that characterize cerebral palsy, which limit a patient's activities, individuals with cerebral palsy often display epilepsy, secondary musculoskeletal problems, and disturbances of sensation, perception, cognition, communication, and behavior.1

Cerebral palsy has traditionally been classified on the basis of the type of motor disorder that occurs, with variable numbers and descriptions of types.2 The revised classification now in use defines 3 main categories of motor disorder, as follows:

  • Spastic - 70-80%
  • Dyskinetic - 10-15%
  • Ataxic - <5%

There are also mixed types.

Spastic cases are further classified according to involvement of the extremities, as follows3 :

  • Quadriplegia - 10-15%; all 4 extremities are affected, and the trunk is involved. (See image below and Image 1.)
Magnetic resonance imaging (MRI) scan of a 16-mon...

Magnetic resonance imaging (MRI) scan of a 16-month-old boy who was born at term but had an anoxic event at delivery. Examination findings are consistent with a spastic quadriplegic cerebral palsy with asymmetry (more prominent right-sided deficits). Cystic encephalomalacia in the left temporal and parietal regions, delayed myelination, decreased white matter volume, and enlarged ventricles can be seen. These findings are most likely the sequelae of a neonatal insult (eg, periventricular leukomalacia with a superimposed, left-sided cerebral infarct).

Magnetic resonance imaging (MRI) scan of a 16-mon...

Magnetic resonance imaging (MRI) scan of a 16-month-old boy who was born at term but had an anoxic event at delivery. Examination findings are consistent with a spastic quadriplegic cerebral palsy with asymmetry (more prominent right-sided deficits). Cystic encephalomalacia in the left temporal and parietal regions, delayed myelination, decreased white matter volume, and enlarged ventricles can be seen. These findings are most likely the sequelae of a neonatal insult (eg, periventricular leukomalacia with a superimposed, left-sided cerebral infarct).

  • Diplegia - 30-40%; the lower extremities are affected more than the upper extremities and in some cases are solely involved. (See image below and Image 2.)
  • Hemiplegia - 20-30%; involvement is observed on 1 side of the body, including an arm and a leg, with the arm more involved than the leg. If both arms are more involved than the legs, the condition can be classified as a double hemiplegia.
  • Monoplegia - Rare; involvement is noted in 1 limb, either an arm or a leg. If a patient has monoplegia, an effort should be made to rule out causes other than cerebral palsy.
Magnetic resonance imaging (MRI) scan of a 1-year...

Magnetic resonance imaging (MRI) scan of a 1-year-old boy who was born at gestational week 27. Clinical examination is consistent with spastic diplegic cerebral palsy. Pseudocolpocephaly and decreased volume of the white matter posteriorly are consistent with periventricular leukomalacia. Evidence of diffuse polymicrogyria and thinning of the corpus callosum is noted.

Magnetic resonance imaging (MRI) scan of a 1-year...

Magnetic resonance imaging (MRI) scan of a 1-year-old boy who was born at gestational week 27. Clinical examination is consistent with spastic diplegic cerebral palsy. Pseudocolpocephaly and decreased volume of the white matter posteriorly are consistent with periventricular leukomalacia. Evidence of diffuse polymicrogyria and thinning of the corpus callosum is noted.


Related eMedicine topic:
Cerebral Palsy [Neurology]

Pathophysiology

Cerebral palsy is caused by an insult to the immature brain; the period during which the insult can occur ranges from any time before birth up to the postnatal period.4 (Some classify cerebral palsy as an insult to the brain before age 3 years.) After the immediate postnatal period, cerebral palsy often has an identifiable cause (eg, hypoxic-ischemic encephalopathy), which should be noted. (See image below and Image 3.) The cerebral insult alters muscle tone, muscle stretch reflexes, primitive reflexes, and postural reactions. Other associated symptoms may be involved secondary to the neurologic insult (eg, mental retardation, vision and hearing problems, seizures), but they are not part of the definition of cerebral palsy.

The etiology of the cerebral insults includes vascular, hypoxic-ischemic, metabolic, infectious, toxic, teratogenic, traumatic, and genetic causes. The pathogenesis of cerebral palsy involves multifactorial causes, but much is still unknown. Different pathogenetic mechanisms of cerebral palsy have been associated with preterm and term births. In many cases, a cause cannot be accurately determined. Some believe that a pre-existing condition in some fetuses causes early birth and neurologic problems, as opposed to the prematurity itself causing cerebral palsy.



Magnetic resonance imaging (MRI) scan of a 9-day-...

Magnetic resonance imaging (MRI) scan of a 9-day-old girl who was born full-term and had a perinatal hypoxic-ischemic event. Examination of the patient at 1 year revealed findings consistent with a mixed quadriparetic cerebral palsy notable for dystonia and spasticity. Severe hypoxic-ischemic injury to the medial aspect of the cerebellar hemispheres, medial temporal lobes, bilateral thalami, and bilateral corona radiata is observed.

Magnetic resonance imaging (MRI) scan of a 9-day-...

Magnetic resonance imaging (MRI) scan of a 9-day-old girl who was born full-term and had a perinatal hypoxic-ischemic event. Examination of the patient at 1 year revealed findings consistent with a mixed quadriparetic cerebral palsy notable for dystonia and spasticity. Severe hypoxic-ischemic injury to the medial aspect of the cerebellar hemispheres, medial temporal lobes, bilateral thalami, and bilateral corona radiata is observed.


Frequency

United States

The prevalence of cerebral palsy is approximately 1.5-2 cases per 1000 live births. The incidence of cerebral palsy has not changed in more than 4 decades, despite significant advances in the medical care of neonates.

International

The prevalence of cerebral palsy is approximately 1.5-2 cases per 1000 live births.

Mortality/Morbidity

Cerebral palsy is the leading cause of childhood disability affecting function and development.

Age

The insult that gives rise to cerebral palsy occurs during immature brain development. According to most references, this initiating event can take place anytime between prenatal development and age 3 years. However, children are usually not diagnosed until after age 1 year, with the condition becoming identifiable as children fail to meet developmental milestones. Often, children who are older and are diagnosed as having cerebral palsy — as a result of having presenting symptoms or problems that are similar to those of cerebral palsy — should instead be labeled with the etiology of their brain injury (ie, traumatic brain injury secondary to a motor vehicle accident, stroke, metabolic condition, etc.)

Clinical

History

  • The child with cerebral palsy can present after failing to meet expected developmental milestones or failing to suppress obligatory primitive reflexes.
  • Abnormal muscle tone is the most frequently observed symptom. The child may present as either hypotonic or, more commonly, hypertonic with either decreased or increased resistance to passive movements, respectively. Children with cerebral palsy may have an early period of hypotonia followed by hypertonia. The longer the period of hypotonia prior to hypertonia, the greater the likelihood that the hypertonia will be more severe.
  • Definite hand preference before age 1 year is a red flag for possible hemiplegia.
  • Asymmetric crawling or failure to crawl also may suggest cerebral palsy.
  • Growth disturbance is often noted in children with cerebral palsy, especially failure to thrive.

Physical

  • Joint contractures secondary to spastic muscles
  • Hypotonic to spastic tone
  • Growth delay
  • Persistent primitive reflexes - Examples such as the Moro, asymmetric tonic neck, symmetric tonic neck, palmar grasp, tonic labyrinthine, and foot placement reflexes are noted. The Moro and tonic labyrinthine reflexes should extinguish by the time the infant is aged 4-6 months; the palmar grasp reflex, by 5-6 months; the asymmetric and symmetric tonic neck reflexes, by 6-7 months; and the foot placement reflex, before 12 months.
  • The overall gait pattern should be observed and each joint in the lower extremity and upper extremity should be assessed.
    • Hip - Excessive flexion, adduction, and femoral anteversion make up the predominant motor pattern. Scissoring of the legs is common in spastic cerebral palsy.
    • Knee - Flexion and extension with valgus or varus stress occur.
    • Foot - Equinus, or toe walking, and varus or valgus of the hindfoot is common in cerebral palsy.
  • Gait abnormalities may include the crouch position with tight hip flexors and hamstrings, weak quadriceps, and/or excessive dorsiflexion.
  • Physical attributes of different types of cerebral palsy
    • The spastic type (pyramidal cerebral palsy) constitutes 75% of patients with cerebral palsy. Patients have signs of upper motor neuron involvement, including hyperreflexia, clonus, extensor Babinski response, persistent primitive reflexes, and overflow reflexes (crossed adductor). Cognitive impairment is present in approximately 30% of spastic diplegic patients, but most patients with spastic quadriplegia have some cognitive impairment.
    • The dyskinetic type (extrapyramidal cerebral palsy) is characterized by extrapyramidal movement patterns, abnormal regulation of tone, abnormal postural control, and coordination deficits. Athetosis, chorea, and choreoathetoid or dystonic movements can be seen. Patients often have pseudobulbar involvement, with dysarthria, swallowing difficulties, drooling, oromotor difficulties, and abnormal speech patterns. Generally, patients are hypotonic at birth, with abnormal movement patterns emerging at 1-3 years. The arms are usually more involved than the legs. Abnormal movement patterns may increase with stress or purposeful activity. Muscle tone is usually normal during sleep. Intelligence is normal in 78% of patients with athetoid cerebral palsy. A high incidence of sensorineural hearing loss is reported.
    • Patients with spastic diplegia often have a period of hypotonia followed by extensor spasticity in the lower extremities, with little or no functional limitation of the upper extremities. Patients have a delay in developing gross motor skills. Spastic muscle imbalance often causes persistence of infantile coxa valga and femoral anteversion. A scissoring gait (ie, hips flexed and adducted, knees flexed with valgus stress, equinus ankles) is observed.
    • Hemiplegia is characterized by weak hip flexion and ankle dorsiflexion, an overactive posterior tibialis muscle, hip hiking/circumduction, supinated foot in stance, upper extremity posturing (that is, often held with the shoulder adducted, elbow flexed, forearm pronated, wrist flexed, hand clenched in a fist with the thumb in the palm), impaired sensation, impaired 2-point discrimination, and/or impaired position sense. Some cognitive impairment is found in about 28% of these patients.

Related eMedicine topics:
Spasticity [Neurology]
Spasticity [Physical Medicine and Rehabilitation]

Causes

  • Prenatal
    • Intrauterine infections5
    • Congenital malformations
    • Toxic or teratogenic agents
    • Multiple births
    • Abdominal trauma
    • Maternal illness
  • Neonatal
    • Prematurity (less than 32 weeks' gestation)
    • Birthweight less than 2500 g
    • Growth retardation
    • Intracranial hemorrhage
    • Trauma
    • Infection
    • Bradycardia and hypoxia
    • Seizures
    • Hyperbilirubinemia
    • Abnormal birthing presentations
  • Postnatal
    • Trauma
    • Infection
    • Intracranial hemorrhage
    • Coagulopathies

More on Cerebral Palsy

Overview: Cerebral Palsy
Differential Diagnoses & Workup: Cerebral Palsy
Treatment & Medication: Cerebral Palsy
Follow-up: Cerebral Palsy
Multimedia: Cerebral Palsy
References

References

  1. Bax M, Goldstein M, Rosenbaum P, et al. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol. Aug 2005;47(8):571-6. [Medline].

  2. Badawi N, Watson L, Petterson B, et al. What constitutes cerebral palsy?. Dev Med Child Neurol. Aug 1998;40(8):520-7. [Medline].

  3. Dabney KW, Lipton GE, Miller F. Cerebral palsy. Curr Opin Pediatr. Feb 1997;9(1):81-8. [Medline].

  4. Jones MW, Morgan E, Shelton JE, et al. Cerebral palsy: introduction and diagnosis (part I). J Pediatr Health Care. May-Jun 2007;21(3):146-52. [Medline].

  5. Girard S, Kadhim H, Roy M, et al. Role of perinatal inflammation in cerebral palsy. Pediatr Neurol. Mar 2009;40(3):168-74. [Medline].

  6. Mayston MJ. People with cerebral palsy: effects of and perspectives for therapy. Neural Plast. 2001;8(1-2):51-69. [Medline].

  7. Mattern-Baxter K. Effects of partial body weight supported treadmill training on children with cerebral palsy. Pediatr Phys Ther. Spring 2009;21(1):12-22. [Medline].

  8. Verrall TC, Berenbaum S, Chad KE, et al. Children with cerebral palsy: caregivers' nutrition knowledge, attitudes and beliefs. Can J Diet Pract Res. 2000;61(3):128-34. [Medline].

  9. Scholtes VA, Dallmeijer AJ, Knol DL, et al. The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial. Arch Phys Med Rehabil. Dec 2006;87(12):1551-8. [Medline].

  10. Dai AI, Wasay M, Awan S. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity. J Child Neurol. Dec 2008;23(12):1464-6. [Medline].

  11. Yang EJ, Rha DW, Kim HW, Park ES. Comparison of botulinum toxin type A injection and soft-tissue surgery to treat hip subluxation in children with cerebral palsy. Arch Phys Med Rehabil. Nov 2008;89(11):2108-13. [Medline].

  12. Pascual-Pascual SI, Pascual-Castroviejo I. Safety of botulinum toxin type A in children younger than 2 years. Eur J Paediatr Neurol. Nov 24 2008;[Medline].

  13. Abstracts of the 5th International Congress on Cerebral Palsy. Bled, Slovenia, 7-10 June 2001. Brain Dev. Jun 2001;23(3):145-93. [Medline].

  14. Kuban KC, Leviton A. Cerebral palsy. N Engl J Med. Jan 20 1994;330(3):188-95. [Medline].

  15. Matthews DJ, Wilson P. Cerebral palsy. In: Molnar GE, Alexander MA, eds. Pediatric Rehabilitation. 3rd ed. Philadelphia, Pa: Hanley & Belfus; 1999:192-217.

  16. Taketomo CT, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 4th ed. Cleveland, Ohio: Lexi-Comp; 1997.

Further Reading

Keywords

cerebral palsy, palsy, spastic, spasticityhemiplegia, quadriplegia, diplegia, palsy treatment, children with cerebral palsy, cerebral palsy symptoms, cerebral palsy treatment, spastic diplegia, spastic cerebral palsy, ataxic cerebral palsy, spastic quadriplegia, spastic monoplegia, cerebral palsy causes, monoplegia, encephalopathy, spastic palsy, dyskinetic palsy, ataxic palsy

Contributor Information and Disclosures

Author

Christine Thorogood, MD, Associate Professor of Pediatric Physical Medicine and Rehabilitation, Eastern Virginia Medical School
Christine Thorogood, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Pediatrics, and American Academy of Physical Medicine and Rehabilitation
Disclosure: Nothing to disclose.

Coauthor(s)

Michael A Alexander, MD, FAAPMR, FAAP, Professor, Chief of Division of Rehabilitation Medicine, Departments of Pediatrics and Rehabilitation Medicine, Thomas Jefferson Medical College; Chief of Rehabilitation Medicine, Alfred I duPont Hospital for Children
Michael A Alexander, MD, FAAPMR, FAAP is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Pediatrics, American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, and Association of Academic Physiatrists
Disclosure: Nothing to disclose.

Medical Editor

Teresa L Massagli, MD, Residency Director, Professor, Department of Rehabilitation Medicine and Pediatrics, University of Washington School of Medicine
Teresa L Massagli, MD is a member of the following medical societies: American Academy of Pediatrics, American Academy of Physical Medicine and Rehabilitation, and Association of Academic Physiatrists
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Kat Kolaski, MD, Assistant Professor, Departments of Orthopedic Surgery and Pediatrics, Wake Forest University School of Medicine
Kat Kolaski, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine and American Academy of Physical Medicine and Rehabilitation
Disclosure: Nothing to disclose.

CME Editor

Kelly L Allen, MD, Regional Medical Director, IMX-Medical Management Services
Disclosure: Nothing to disclose.

Chief Editor

Denise I Campagnolo, MD, MS, Director of Multiple Sclerosis Clinical Research and Staff Physiatrist, Barrow Neurology Clinics, St Joseph's Hospital and Medical Center; Investigator for Barrow Neurology Clinics; Director, NARCOMS Project for Consortium of MS Centers
Denise I Campagnolo, MD, MS is a member of the following medical societies: Alpha Omega Alpha, American Association of Neuromuscular and Electrodiagnostic Medicine, American Paraplegia Society, Association of Academic Physiatrists, and Consortium of Multiple Sclerosis Centers
Disclosure: Teva Neuroscience Honoraria Speaking and teaching; Serono-Pfizer Honoraria Speaking and teaching

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.